NEW YORK (GenomeWeb) – Invitae reported after the close of the market on Monday that its second quarter revenues more than doubled year over year, beating the consensus Wall Street estimate.

The San Francisco-based genetic testing firm posted revenues of $14.3 million for the three-month period ended June 30, compared with $5.6 million for the second quarter of 2016. Analysts' consensus estimate for the quarter was $13.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.